Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00892125
What this trial is testing

The Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder

Who this might be right for
SchizophreniaBipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 64
Post-approval studies (Phase 4)Study completedNCT02298985
What this trial is testing

Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients

Who this might be right for
Chronic Schizophrenia
Beersheva Mental Health Center 38
Post-approval studies (Phase 4)Study completedNCT02534363
What this trial is testing

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up

Who this might be right for
SchizophreniaPsychotic Disorders
Fundación Marques de Valdecilla 136
Early research (Phase 1)Active Not RecruitingNCT03741478
What this trial is testing

Intranasal Insulin and Olanzapine Study in Healthy Volunteers

Who this might be right for
Healthy Controls
Centre for Addiction and Mental Health 64
Large-scale testing (Phase 3)Looking for participantsNCT05669742
What this trial is testing

Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients

Who this might be right for
Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
Tanta University 40
Not applicableStudy completedNCT03005769
What this trial is testing

Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Europe Ltd 262
Large-scale testing (Phase 3)UnknownNCT00999505
What this trial is testing

Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia

Who this might be right for
Schizophrenia
Hospital de Clinicas de Porto Alegre 40
Post-approval studies (Phase 4)Study completedNCT00740259
What this trial is testing

Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol

Who this might be right for
Schizophrenia
Ambulatório de Bipolaridade 70
Post-approval studies (Phase 4)Looking for participantsNCT06997198
What this trial is testing

Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

Who this might be right for
Tardive DyskinesiaIntellectual DisabilityDevelopmental Disabilities
University Hospitals Cleveland Medical Center 25
Not applicableWithdrawnNCT01758887
What this trial is testing

Antipsychotic Discontinuation in High-risk Subjects

Who this might be right for
Schizophrenia
Seoul National University Hospital
Post-approval studies (Phase 4)Ended earlyNCT05662306
What this trial is testing

C-Cog in Early Course Schizophrenia Study

Who this might be right for
Schizophrenia
University of Miami 1
Not applicableUnknownNCT02964923
What this trial is testing

Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Xijing Hospital 300
Post-approval studies (Phase 4)Study completedNCT00148564
What this trial is testing

Energy Homeostasis Under Treatment With Atypical Antipsychotics

Who this might be right for
Schizophrenia
Charite University, Berlin, Germany 40
Testing effectiveness (Phase 2)Study completedNCT00845026
What this trial is testing

A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients

Who this might be right for
Schizophrenia
Denovo Biopharma LLC 261
Post-approval studies (Phase 4)UnknownNCT02282085
What this trial is testing

Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia

Who this might be right for
Schizophrenia
Matt Byerly 200
Testing effectiveness (Phase 2)Study completedNCT00057408
What this trial is testing

A Controlled Study of Olanzapine in Children With Autism

Who this might be right for
Autistic Disorder
FDA Office of Orphan Products Development 78
Not applicableStudy completedNCT00538122
What this trial is testing

Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder
Vanderbilt University 12
Post-approval studies (Phase 4)Study completedNCT07545382
What this trial is testing

Rivastigmine as an Antidote for Clozapine-induced Central Nervous System Depression and Delirium

Who this might be right for
Anticholinergic DeliriumClozapine PoisoningAntipsychotic Toxicity+4 more
Alexandria University 100
Post-approval studies (Phase 4)Study completedNCT02307396
What this trial is testing

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

Who this might be right for
SchizophreniaSchizophrenia and Disorders With Psychotic FeaturesSchizoaffective Disorders
Technical University of Munich 21
Not applicableUnknownNCT04291469
What this trial is testing

Antipsychotic Effects of Probiotics and Prebiotics on Patients With Schizophrenia

Who this might be right for
Schizophrenia
First Affiliated Hospital Xi'an Jiaotong University 200
Next Page